0001415889-21-000526.txt : 20210203 0001415889-21-000526.hdr.sgml : 20210203 20210203191044 ACCESSION NUMBER: 0001415889-21-000526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALLEN HUBERT L CENTRAL INDEX KEY: 0001565916 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 21588045 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02032021_040226.xml X0306 4 2021-02-01 0000001800 ABBOTT LABORATORIES ABT 0001565916 ALLEN HUBERT L 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false EXECUTIVE VICE PRESIDENT Common shares without par value 2021-02-01 4 M 0 107793 39.12 A 259689 D Common shares without par value 2021-02-01 4 M 0 95600 38.40 A 355289 D Common shares without par value 2021-02-01 4 S 0 201343 123.4659 D 153946 D Common shares without par value 2021-02-01 4 S 0 2050 124.0278 D 151896 D Option (right to buy) 39.12 2021-02-01 4 M 0 107793 0 D 2017-02-21 2024-02-20 Common Shares 107793 0 D Option (right to buy) 38.40 2021-02-01 4 M 0 95600 0 D 2019-02-19 2026-02-18 Common Shares 95600 189788 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.00 to $123.99, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 to $124.19, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). /s/ Hubert L. Allen by Jessica H. Paik, Attorney-in-Fact 2021-02-03